India is expected to see an upward trajectory in deal activity in 2024, according to a report by Bain & Company's Global Healthcare Private Equity and M&A report. The report cites a surge in healthcare spending and the resilience of pharma manufacturing and services. India overtook China in 2022 in deal volume and value size, and remained top in the Asia Pacific region in 2023. The report predicts 22 healthcare deals in 2023, with deal value reaching $4.6 billion.
